• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

特发性肺纤维化:揭开特发性环境因素的面纱。

Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors.

机构信息

Dept of Medicine, University of Washington, Seattle, WA, USA.

Center for Interstitial Lung Disease, University of Washington, Seattle, WA, USA.

出版信息

Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01699-2018. Print 2019 Feb.

DOI:10.1183/13993003.01699-2018
PMID:30487201
Abstract

Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease of unknown origin that is associated with high morbidity and mortality. In this perspective, we briefly review the current understanding of the pathophysiology of IPF and the importance of environmental triggers as a precipitant of disease. We discuss occult intrinsic and extrinsic environmental factors that affect the lung microenvironment and may contribute to the development and progression of disease. The clinical implications of this framework need to be further elucidated, because prompt identification and elimination of occult exposures may represent a novel treatment modality.

摘要

特发性肺纤维化(IPF)是一种病因不明的进行性肺纤维化疾病,其发病率和死亡率都很高。从这个角度来看,我们简要回顾了对 IPF 病理生理学的现有理解,以及环境诱因作为疾病诱发因素的重要性。我们讨论了影响肺微环境并可能导致疾病发展和进展的隐匿内在和外在环境因素。需要进一步阐明这一框架的临床意义,因为及时识别和消除隐匿暴露可能代表一种新的治疗方式。

相似文献

1
Idiopathic pulmonary fibrosis: unmasking cryptogenic environmental factors.特发性肺纤维化:揭开特发性环境因素的面纱。
Eur Respir J. 2019 Feb 21;53(2). doi: 10.1183/13993003.01699-2018. Print 2019 Feb.
2
Epigenetics of idiopathic pulmonary fibrosis.特发性肺纤维化的表观遗传学
Transl Res. 2015 Jan;165(1):48-60. doi: 10.1016/j.trsl.2014.03.011. Epub 2014 Mar 31.
3
Familial pulmonary fibrosis is the strongest risk factor for idiopathic pulmonary fibrosis.家族性肺纤维化是特发性肺纤维化的最强危险因素。
Respir Med. 2011 Dec;105(12):1902-7. doi: 10.1016/j.rmed.2011.08.022. Epub 2011 Sep 13.
4
Novel mechanisms and treatment of idiopathic pulmonary fibrosis.特发性肺纤维化的新机制与治疗
Discov Med. 2015 Sep;20(109):145-53.
5
Idiopathic pulmonary fibrosis and occupational risk factors.特发性肺纤维化与职业危险因素。
Med Lav. 2019 Dec 17;110(6):407-436. doi: 10.23749/mdl.v110i6.8970.
6
The Role of Occupational and Environmental Exposures in the Pathogenesis of Idiopathic Pulmonary Fibrosis: A Narrative Literature Review.职业和环境暴露在特发性肺纤维化发病机制中的作用:一项叙述性文献综述
Medicina (Kaunas). 2018 Dec 10;54(6):108. doi: 10.3390/medicina54060108.
7
Idiopathic pulmonary fibrosis: the turning point is now!特发性肺纤维化:转折点已至!
Swiss Med Wkly. 2015 May 29;145:w14139. doi: 10.4414/smw.2015.14139. eCollection 2015.
8
The Interplay of the Genetic Architecture, Aging, and Environmental Factors in the Pathogenesis of Idiopathic Pulmonary Fibrosis.遗传结构、衰老和环境因素在特发性肺纤维化发病机制中的相互作用。
Am J Respir Cell Mol Biol. 2021 Feb;64(2):163-172. doi: 10.1165/rcmb.2020-0373PS.
9
Air Pollution Exposure Is Associated With Lower Lung Function, but Not Changes in Lung Function, in Patients With Idiopathic Pulmonary Fibrosis.空气污染暴露与特发性肺纤维化患者的肺功能下降相关,但与肺功能变化无关。
Chest. 2018 Jul;154(1):119-125. doi: 10.1016/j.chest.2018.01.015. Epub 2018 Feb 7.
10
Environmental Causes of Idiopathic Pulmonary Fibrosis.特发性肺纤维化的环境病因。
Int J Mol Sci. 2023 Nov 18;24(22):16481. doi: 10.3390/ijms242216481.

引用本文的文献

1
The Role of Particle Inhalation in Idiopathic Pulmonary Fibrosis.颗粒物吸入在特发性肺纤维化中的作用
Int J Mol Sci. 2025 Sep 8;26(17):8736. doi: 10.3390/ijms26178736.
2
Ectopic Expansion of Pulmonary Vasculature in Fibrotic Lung Disease and Lung Adenocarcinoma Marked by Proangiogenic COL15A1+ Endothelial Cells.以促血管生成的COL15A1 + 内皮细胞为特征的肺纤维化疾病和肺腺癌中肺血管的异位扩张。
Pulm Circ. 2025 Jun 3;15(2):e70102. doi: 10.1002/pul2.70102. eCollection 2025 Apr.
3
Autophagy inhibition enhances antifibrotic potential of placental mesenchymal stem cells of fetal origin via regulating TGF-β1 mediated protein degradation of HGF.自噬抑制通过调节转化生长因子-β1介导的肝细胞生长因子蛋白降解增强胎儿来源的胎盘间充质干细胞的抗纤维化潜能。
Sci Rep. 2025 Apr 21;15(1):13805. doi: 10.1038/s41598-025-97054-8.
4
Quantifying Titanium Exposure in Lung Tissues: A Novel Laser-Induced Breakdown Spectroscopy Elemental Imaging-Based Analytical Framework for Biomedical Applications.量化肺组织中的钛暴露:一种基于激光诱导击穿光谱元素成像的新型生物医学应用分析框架。
Small Sci. 2024 Mar 3;4(5):2300307. doi: 10.1002/smsc.202300307. eCollection 2024 May.
5
Semaphorin 3E-Plexin D1 Axis Drives Lung Fibrosis through ErbB2-Mediated Fibroblast Activation.信号素3E-丛状蛋白D1轴通过表皮生长因子受体2介导的成纤维细胞激活驱动肺纤维化。
Adv Sci (Weinh). 2025 May;12(18):e2415007. doi: 10.1002/advs.202415007. Epub 2025 Mar 20.
6
Elucidating the causal associations and mechanisms between circulating immune cells and idiopathic pulmonary fibrosis: new insights from Mendelian randomization and transcriptomics.阐明循环免疫细胞与特发性肺纤维化之间的因果关联及机制:孟德尔随机化和转录组学的新见解
Front Immunol. 2025 Jan 17;15:1437984. doi: 10.3389/fimmu.2024.1437984. eCollection 2024.
7
Inhibition of AXL ameliorates pulmonary fibrosis attenuation of M2 macrophage polarisation.抑制AXL可改善肺纤维化,减少M2巨噬细胞极化。
Eur Respir J. 2025 Jun 5;65(6). doi: 10.1183/13993003.00615-2024. Print 2025 Jun.
8
Idiopathic Pulmonary Fibrosis Caused by Damaged Mitochondria and Imbalanced Protein Homeostasis in Alveolar Epithelial Type II Cell.线粒体损伤和肺泡II型上皮细胞蛋白质稳态失衡导致的特发性肺纤维化
Adv Biol (Weinh). 2025 Apr;9(4):e2400297. doi: 10.1002/adbi.202400297. Epub 2024 Oct 10.
9
Highlights on Future Treatments of IPF: Clues and Pitfalls.特刊:特发性肺纤维化的未来治疗方法:线索与陷阱
Int J Mol Sci. 2024 Aug 1;25(15):8392. doi: 10.3390/ijms25158392.
10
"A Mighty Flame Can Follow a Tiny Spark": Is This the Case of c-Jun N-Terminal Kinase 1 Inhibitors in Idiopathic Pulmonary Fibrosis?“星星之火,可以燎原”:这是否适用于c-Jun氨基末端激酶1抑制剂治疗特发性肺纤维化的情况?
Am J Respir Crit Care Med. 2024 Aug 15;210(4):376-377. doi: 10.1164/rccm.202403-0574ED.